Antimicrobial De-escalation Strategy in Medical Patients.

Trial Profile

Antimicrobial De-escalation Strategy in Medical Patients.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2010

At a glance

  • Drugs Meropenem (Primary) ; Piperacillin/tazobactam (Primary)
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 17 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top